Download Presentation: Engineering strategies to generate site-specific ADC’s

Developing therapeutic monoclonal antibodies and ADC's is a key focus of the pharmaceutical industry's R&D. The European Antibody Congress 2012 bought together senior level executives and opinion leaders from around the globe to further their knowledge and engage in discussion on a variety of topics relating to mAbs, ADC's and bispecifics. Attendees at this highly successful event were fortunate enough …

The Big Antibody Debate – Share your opinions and make a difference

In return for the chance to secure a 2-day delegate ticket* to Europe's leading Antibody and Next Gen Tech. Congress later this year; the 9th European Antibody Congress would like 3mins of your time. We`re canvassing the brightest stakeholders in the industry to hear what their thoughts are on the current state of play of the antibody and next generations …